Cristina Florean

Dr. Cristina Florean


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
CMCeline Moriou
Celine Moriou
DLDamien Lacroix
Damien Lacroix
SPSylvain Petek
Sylvain Petek
Amr El-DemerdashAmr El-Demerdash
Amr El-Demerdash
RTrozenn trepos
rozenn trepos
AAAl-Mourabit Ali
Al-Mourabit Ali
Chemical investigation of the South-Pacific marine sponge Suberea clavata led to the isolation of eight new bromotyrosine metabolites named subereins 1–8 (2–9) along with twelve known co-isolated congeners. The detailed configuration determination of the first representative major compound of this family 11-epi-fistularin-3 (11R,17S) (1) is described. Their chemical characterization was achieved by HRMS and integrated 1D and 2D NMR (nuclear magnetic resonance) spectroscopic studies and extensive comparison with literature data. For the first time, a complete assignment of the absolute configurations for stereogenic centers C-11/17 of the known members (11R,17S) 11-epi-fistularin-3 (1) and 17-deoxyfistularin-3 (10) was determined by a combination of chemical modifications, Mosher’s technology, and ECD spectroscopy. Consequently, the absolute configurations of all our new isolated compounds 2–9 were determined by the combination of NMR, Mosher’s method, ECD comparison, and chemical modifications. Interestingly, compounds 2–7 were obtained by chemical transformation of the major compound 11-epi-fistularin-3 (1). Evaluation for acetylcholinesterase inhibition (AChE), DNA methyltransferase 1 (DNMT1) modulating activity and antifouling activities using marine bacterial strains are also presented.

19 December 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
CFCristina Florean
Cristina Florean
KKKyung Rok Kim
Kyung Rok Kim
MSMichael Schnekenburger
Michael Schnekenburger
HKHyun-Jung Kim
Hyun-Jung Kim
CMCeline Moriou
Celine Moriou
MDMarc Diederich
Marc Diederich
Treatment of acute myeloid leukemia (AML) patients is still hindered by resistance and relapse, resulting in an overall poor survival rate. Recently, combining specific B-cell lymphoma (Bcl)-2 inhibitors with compounds downregulating myeloid cell leukemia (Mcl)-1 has been proposed as a new effective strategy to eradicate resistant AML cells. We show here that 1(R), 6(S), 1’(R), 6’(S), 11(R), 17(S)-fistularin-3, a bromotyrosine compound of the fistularin family, isolated from the marine sponge Suberea clavata, synergizes with Bcl-2 inhibitor ABT-199 to efficiently kill Mcl-1/Bcl-2-positive AML cell lines, associated with Mcl-1 downregulation and endoplasmic reticulum stress induction. The absolute configuration of carbons 11 and 17 of the fistularin-3 stereoisomer was fully resolved in this study for the first time, showing that the fistularin we isolated from the marine sponge Subarea clavata is in fact the (+)-11(R), 17(S)-fistularin-3 stereoisomer keeping the known configuration 1(R), 6(S), 1’(R), and 6’(S) for the verongidoic acid part. Docking studies and in vitro assays confirm the potential of this family of molecules to inhibit DNA methyltransferase 1 activity.

19 April 2019 in Proceedings
Verified
Conference Paper
Open access
PDF file
MSMichael Schnekenburger
Michael Schnekenburger
HLHélène Losson
Hélène Losson
MLManon Lernoux
Manon Lernoux
CFCristina Florean
Cristina Florean
MDMario Dicato
Mario Dicato
MDMarc Diederich
Marc Diederich
Epigenetics refers to the study of heritable changes in gene function that are mediated by mechanisms other than nucleotide alterations in the primary DNA sequence